Si Bone Stock Investor Sentiment

SIBN Stock  USD 17.47  0.37  2.07%   
About 56% of Si Bone's investor base is looking to short. The analysis of overall sentiment of trading Si Bone stock suggests that many investors are alarmed at this time. Si Bone's investing sentiment overview a quick insight into current market opportunities from investing in Si Bone. Many technical investors use Si Bone stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  

Si Bone Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Si Bone can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Si Bone Maximum Pain Price Across April 17th 2025 Option Contracts

Si Bone's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Si Bone close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Si Bone's options.
over two weeks ago at news.google.com         
Acquisition by Francis Laura of 30579 shares of Si Bone subject to Rule 16b-3
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
SI-BONE shareholders have endured a 20 percent loss from investing in the stock five years ago
Yahoo News
over two weeks ago at zacks.com         
CVRx Reports Q4 Loss, Tops Revenue Estimates
zacks News
over three weeks ago at gurufocus.com         
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025
Gurufocus Stories at Macroaxis
over three weeks ago at gurufocus.com         
Disposition of 337 shares by Jeffrey Dunn of Si Bone at 16.5056 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over three weeks ago at news.google.com         
On The My Stocks Page - Stock Traders Daily
Google News at Macroaxis
over a month ago at news.google.com         
SI-BONE FY2024 EPS Forecast Increased by Cantor Fitzgerald - MarketBeat
Google News at Macroaxis
over a month ago at simplywall.st         
SI-BONE, Inc. Looks Just Right With A 26 percent Price Jump
Simply Wall St News at Macroaxis
over a month ago at thelincolnianonline.com         
SI-BONEs Buy Rating Reiterated at Needham Company LLC
news
over a month ago at simplywall.st         
SI-BONE adds US88m to market cap in the past 7 days, though investors from three years ago are still...
Simply Wall St News at Macroaxis
over a month ago at gurufocus.com         
SI-BONE Inc Stock Price Down 7.33 percent on Jan 14
Gurufocus Stories at Macroaxis
over a month ago at benzinga.com         
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
benzinga news
over a month ago at gurufocus.com         
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024
Gurufocus Stories at Macroaxis
over a month ago at news.google.com         
SI-BONE, Inc. Shares Purchased by Harbor Capital Advisors Inc. - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Si-Bones president of commercial ops sells 51,014 in stock By Investing.com - Investing.com Nigeria
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Si Bone that are available to investors today. That information is available publicly through SIBN media outlets and privately through word of mouth or via SIBN internal channels. However, regardless of the origin, that massive amount of SIBN data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Si Bone news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Si Bone relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Si Bone's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Si Bone alpha.

Si Bone Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 3165 shares by Francis Laura of Si Bone at 13.8344 subject to Rule 16b-3
11/27/2024
2
Disposition of 1726 shares by Anshul Maheshwari of Si Bone at 13.9093 subject to Rule 16b-3
01/02/2025
3
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
01/13/2025
4
SI-BONE adds US88m to market cap in the past 7 days, though investors from three years ago are still down 28
01/14/2025
5
SI-BONE FY2024 EPS Forecast Increased by Cantor Fitzgerald - MarketBeat
01/23/2025
6
SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025
02/03/2025
7
Acquisition by Francis Laura of 30579 shares of Si Bone subject to Rule 16b-3
02/05/2025
8
Disposition of 57392 shares by Francis Laura of Si Bone at 4.32 subject to Rule 16b-3
02/07/2025
9
Disposition of 824 shares by Anthony Recupero of Si Bone at 20.955 subject to Rule 16b-3
02/13/2025
10
Disposition of 1619 shares by Jeffrey Dunn of Si Bone at 16.7706 subject to Rule 16b-3
02/18/2025
11
SI-BONE Insiders Sell US1.0m Of Stock, Possibly Signalling Caution
02/19/2025
12
Si-Bone Q4 Earnings Snapshot
02/24/2025
When determining whether Si Bone offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Si Bone's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Si Bone Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Si Bone Stock:
Check out Si Bone Hype Analysis, Si Bone Correlation and Si Bone Performance.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.91)
Revenue Per Share
4.032
Quarterly Revenue Growth
0.261
Return On Assets
(0.1)
Return On Equity
(0.18)
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.